Rentokil Initial plc (FTSE: RTO, NYSE: RTO), the global pest control and hygiene services group, has announced the appointment of Duncan Palmer as a Non-executive Director with immediate effect. Palmer brings extensive CFO experience from Cushman & Wakefield, RELX plc, and Owens Corning, as well as senior finance roles at Shell. The company also confirmed that existing Non-executive Director David Frear will step down from the Board on 30 November 2026, after four years of service.

Key Points

  • Rentokil Initial plc (FTSE: RTO, NYSE: RTO)
  • Duncan Palmer appointed as Non-executive Director with immediate effect, joining the Audit Committee and Nomination Committee
  • David Frear to leave the Board on 30 November 2026 after four years
  • Investors may be watching how Palmer's M&A integration and cost-reduction expertise supports Rentokil's North America strategy

Duncan Palmer's CFO Background at Cushman & Wakefield, RELX and Shell

Palmer's CV spans several prominent listed businesses. He most recently served as Chief Financial Officer of Cushman & Wakefield (NYSE: CWK), where the announcement states he played a leading role in consolidation, integration strategy, and the company's US public offering. Prior to that, he held CFO roles at RELX plc (FTSE: RELX) and Owens Corning (NYSE: OC), and occupied a series of finance leadership positions at Shell. He currently serves as a Non-executive Director at Oshkosh Corporation (NYSE: OSK), where he chairs the Audit Committee, and also holds directorships at Aleanna and Verde Clean Fuels.

Palmer to Join Rentokil's Audit Committee and Nomination Committee

Alongside his Board appointment, Palmer will become a member of both Rentokil Initial's Audit Committee and Nomination Committee. The announcement describes him as a UK Chartered Management Accountant who holds an MBA from Stanford Graduate School of Business and an MA from St John's College, Cambridge. His governance credentials and track record in back-office rationalisation and M&A integration are cited as directly relevant to Rentokil's current operational priorities, particularly as the company continues to execute its strategic plans in North America following its acquisition of Terminix.

David Frear to Leave the Rentokil Initial Board on 30 November 2026

Concurrently with Palmer's arrival, Rentokil Initial confirmed that David Frear will step down from the Board effective 30 November 2026. Chair Thérèse Esperdy is quoted in the announcement thanking Frear for his contributions to the Board, Remuneration Committee, and Nomination Committee during his four years of service. The departure appears to represent an orderly transition rather than any disclosed dispute or governance concern, with Rentokil making no further comment on the circumstances of Frear's exit beyond confirming the effective date.

North America Integration Remains a Key Focus for Rentokil Initial Investors

Rentokil Initial operates across pest control, hygiene, and workwear services in markets worldwide, with North America representing a significant growth and integration challenge following recent acquisitions. Palmer's stated expertise in M&A integration and cost-reduction programmes may be viewed as particularly relevant in this context. The company did not disclose any changes to financial guidance, remuneration arrangements for Palmer, or further strategic detail in connection with this directorate announcement.